ARICEPT

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ARICEPT contains one active pharmaceutical ingredient (API):

1 Donepezil UNII 3O2T2PJ89D - DONEPEZIL HYDROCHLORIDE

Donepezil hydrochloride is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain. Donepezil hydrochloride is in vitro over 1000 times more potent an inhibitor of this enzyme than of butyrylcholinesterase, an enzyme that is present mainly outside the central nervous system. Read about Donepezil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ARICEPT Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
ARICEPT Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06DA02	Donepezil	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11922L, 11924N, 2479L, 2532G, 8495D, 8496E
Country: CA	Health Products and Food Branch	Identifier(s): 02232043, 02232044, 02269457, 02269465
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00432774, 01086268, 01603864, 01603870, 01699539, 02475150, 02953514, 03552562, 06705960, 08490512, 08490529, 08490535, 08490558, 08490564, 08490570, 09722551, 13248351, 13826210, 15881561
Country: EE	Ravimiamet	Identifier(s): 1030374, 1030385
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1-22057, 3400937306447, 61869, 61870, 68213, 68214, 75519, 76110, 76110-4-12-2006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 454439, 454686
Country: FR	Base de données publique des médicaments	Identifier(s): 62262995, 62650485, 69050347, 69972923
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 111334, 111337, 141965, 141967, 161390, 161392, 175330, 26950, 26956
Country: HK	Department of Health Drug Office	Identifier(s): 42885, 42889, 58711, 58712, 61846
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-615262859, HR-H-681092208
Country: IE	Health Products Regulatory Authority	Identifier(s): 13013, 13080
Country: IT	Agenzia del Farmaco	Identifier(s): 033254018, 033254020, 033254210, 033254309
Country: JP	医薬品医療機器総合機構	Identifier(s): 1190012C1020, 1190012F1026, 1190012F2022, 1190012F3029, 1190012F4025, 1190012F5021, 1190012F6028, 1190012Q1027, 1190012Q2023, 1190012Q3020, 1190012R1022
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12007, 12008, 7917, 7918
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100079234, 100079240, 100335810, 100358419
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64846001, W64846002, W64847001, W64847002
Country: SG	Health Sciences Authority	Identifier(s): 09957P, 09958P, 13645P, 13646P, 14575P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8013042, 8013045
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308071002, 8681308071019, 8681308091062, 8681308091079, 8681308091086, 8681308096708
Country: US	FDA, National Drug Code	Identifier(s): 55289-151, 62856-245, 62856-246, 62856-247, 62856-831, 62856-832
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/5.3/0315, 32/5.3/0316